Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.454
+0.062 (15.69%)
At close: Dec 27, 2024, 4:00 PM
0.416
-0.037 (-8.18%)
After-hours: Dec 27, 2024, 7:50 PM EST

Oragenics Revenue

In the year 2023, Oragenics had annual revenue of $37.65K, down -71.37%.

Revenue (ttm)
$37.65K
Revenue Growth
-71.37%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
5.54M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202337.65K-93.87K-71.37%
Dec 31, 2022131.52K44.53K51.20%
Dec 31, 202186.99K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Biomerica 5.51M
Tenon Medical 3.32M
Sintx Technologies 3.25M
FOXO Technologies 1.34M
Syros Pharmaceuticals 386.00K
Organovo Holdings 103.00K
Revenue Rankings